Alternative macrophage activation, which relies on mitochondrial oxidative metabolism, plays a central role in the resolution of inflammation and prevents atherosclerosis. Moreover, macrophages handle large amounts of cholesterol and triglycerides derived from the engulfed modified lipoproteins during atherosclerosis. Although several microRNAs regulate macrophage polarization, the role of the microRNA-generating enzyme Dicer in macrophage activation during atherosclerosis is unknown.
A t bifurcations and curvatures of arteries, circulating lipoproteins such as low-density lipoproteins (LDLs) enter the vessel wall through leaky junctions frequently associated with enhanced endothelial cell turnover. 1, 2 In the subendothelial space, chemical modifications of LDL result in the unrestricted uptake of these particles by monocyte-derived macrophages through scavenger receptors such as CD36. 3 Surplus lipids that cannot be introduced into the reverse cholesterol transport or degraded by mitochondrial β-oxidation are stored as cholesteryl ester and triglycerides in lipid droplets. Excessive lipid accumulation in lesional macrophages (a process called foam cell formation) is associated with increased oxygen consumption in early atherosclerosis, indicating a role of mitochondria in managing lipid excess by fatty acid oxidation (FAO). [4] [5] [6] However, oxygen consumption declines during lesion progression, which may decrease the degradation of triglycerides and thereby promote macrophage apoptosis. 5, 7 The high lipid content of dead foam cells in turn poses a metabolic threat to macrophages clearing the vessel wall. 8 Engulfment of apoptotic cells upregulates ATP-binding cassette transporters ABCA1 and ABCG1 by nuclear receptors retinoid X receptor (RXR) heterodimers, which protects the efferocyte from apoptosis as a result of cholesterol overload by increasing cholesterol efflux and increases phagocytosis. [9] [10] [11] In advanced atherosclerosis, efferocytosis is defective, leading to the formation of a necrotic core consisting of cell debris and thrombogenic lipids. 12 The necrotic core characterizes vulnerable lesions that are prone to rupture and result in thrombotic obstruction of arteries. 13 Inflammatory activation of macrophages by Toll-like receptor 4 agonists such as lipopolysaccharide results in intracellular lipid storage and foam cell formation by activating the transcription factor hypoxia-inducible factor-1α, which shifts energy metabolism from FAO and oxidative phosphorylation (OXPHOS) to glycolysis. 4, [14] [15] [16] Instead of producing ATP, mitochondria in lipopolysaccharide-stimulated macrophages primarily generate reactive oxygen species, which promote their proinflammatory state and antimicrobial activity. 17, 18 Moreover, oxygen is used to produce nitric oxide after lipopolysaccharide-induced upregulation of nitric oxide synthase 2. 19, 20 By replacing oxidative energy production, glycolytic ATP synthesis protects inflammatory macrophages from cell death. 21 In contrast, alternative macrophage activation by interleukin-4 (IL-4) limits lipid droplet formation; increases oxygen consumption, FAO, and OXPHOS; and promotes an anti-inflammatory phenotype. 22 IL-4 induces the transcription of genes involved in FAO and mitochondrial biogenesis through STAT6-mediated upregulation of peroxisome proliferator-activated receptor (PPAR)-γ coactivator (PGC)-1β, 23, 24 which is a transcriptional coactivator of PPARα and nuclear respiratory factor 1. 24 In addition, sirtuin1 (Sirt1) activates PGC-1β by deacetylation and promotes FAO in macrophages during inflammation resolution. 25, 26 The increased OXPHOS in alternatively activated macrophages (AAMs) is associated with prolonged survival, downregulation of nitric oxide synthase 2, and improved phagocytosis. 22, 27 MicroRNAs (miRNAs) regulate macrophage activation by promoting (eg, miR-155) or inhibiting (eg, miR-223) inflammatory signaling pathways. 28, 29 Moreover, miRNAs play key roles in macrophage cholesterol metabolism, for instance, through suppression of cholesterol efflux by targeting ABCA1, and are involved in foam cell formation. 28 In atherosclerosis, upregulation of miR-155 in foam cells enhances necrotic core formation by inhibiting efferocytosis. 30 The endoribonuclease Dicer produces 21-to 25-nucleotide-long RNA duplexes by cleaving the terminal loop of precursor miRNAs and transfers the duplexes to Argonaut proteins in the RNA-induced silencing complexes, which are activated by removal of one of the strands of the RNA duplexes. 31 Because of the short seed sequence of 6 to 7 nucleotides, miRNAs usually bind to hundreds of target mRNAs, and conversely, 1 mRNA transcript can be targeted by multiple miRNAs. 32 It is notable that global miRNA expression is substantially decreased in macrophages from cigarette smokers as a result of inhibition of Dicer by SUOMylation. 33 In mice, Dicer knockout increases inflammatory activation of tumor-associated macrophages, 34 suggesting that Dicer may play a role in macrophage polarization. However, the concerted effect of the miRNA network in macrophages on atherosclerosis is still incompletely understood.
In the present study, we identified Dicer as a positive regulator of FAO and OXPHOS in macrophages, which promoted an AAM phenotype and limited foam cell formation. In mice, Dicer knockout in macrophages fostered atherosclerosis characterized by enhanced inflammation, foam cell formation, macrophage apoptosis, and necrot-
Clinical Perspective
What Is New?
• MicroRNA biogenesis, for example, of the microRNAs miR-10a and let-7b, promotes the degradation of fatty acids by mitochondrial respiration in macrophages, which reduces intracellular lipid storage and limits atherosclerosis.
What Are the Clinical Implications?
• Reducing foam cell formation in atherosclerotic arteries by enhancing energy metabolism through microRNA-mediated fatty acid oxidation may be a promising approach for the treatment of atherosclerosis.
Circulation. ORIGINAL RESEARCH ARTICLE ic core formation in the lesions. Dicer generated miRNAs such as miR-10a and let-7b, which increased mitochondrial respiration by targeting corepressors of nuclear receptors such as ligand-dependent nuclear receptor corepressor (Lcor). Blocking the interaction between miR-10a and Lcor aggravated atherosclerosis progression in mice. Therefore, Dicer and miRNAs (eg, miR-10a) integrate the immune system and lipid metabolism by promoting FAO and OXPHOS during macrophage activation through inhibiting the corepressors of nuclear receptors, which prevents atherosclerosis.
METHODS

Data Disclosure Statement
The data that support the findings of this study are available from the corresponding author on reasonable request. 
Animal Models
Transfection
Lipofectamine RNAiMAX Reagent (Thermo Fisher Scientific) was used to transfect murine bone marrow-derived macrophages (BMDMs) with mirVana miRNA mimics (30 nmol/L; Thermo Fisher Scientific), LNA-modified miRNA inhibitors (50 nmol/L; Exiqon), GapmeRs (50 nmol/L; Exiqon), target site blockers (TSBs; 50 nmol/L; Exiqon), or scrambled controls. The sequences of miRNA inhibitors, GapmeRs, and TSBs are listed in Table I in the online-only Data Supplement.
Anti-Argonaute 2 RNA Immunoprecipitation Chip (AGO2-RIP-Chip)
The AGO2-RIP of Dicer +/+ or Dicer −/− BMDMs was performed as described previously. 29 Input RNA and AGO2-or immunoglobulin G (IgG)-immunoprecipitated (IP) RNA were reverse transcribed and preamplified with Ovation PicoSL WTA System V2 (NuGEN) followed by the microarray analysis. Agilent SurePrint G3 Mouse Gene Expression microarrays (8×60 K format, Agilent Technologies) were used in combination with a 1-color-based hybridization protocol (IMGM Laboratories GmbH). Raw signals on the microarrays were scanned with the Agilent DNA Microarray Scanner (Agilent Technologies).
To quantify the gene enrichment in AGO2 complexes, RIPchip data were analyzed according to a method described previously. 36 Probe intensity values were estimated with Feature Extraction 10.7.3.1 software (Agilent Technologies). All arrays were quantile normalized. Enrichment values were computed for AGO2-IP against input, AGO2-IP against IgG-IP, and IgG-IP against input (for our results, we used the enrichment of AGO2-IP against IgG-IP). To account for differing pulldown efficiencies, a second normalization was performed on enrichment values using principal component analysis. Significantly enriched genes were determined with a normal mixture modeling approach to distinguish nonassociated mRNAs from mRNAs enriched in AGO2 complexes. Because the background distribution of intensity values from Agilent arrays is different from Affymetrix arrays used in previously, 36 the normal mixture models were only estimated by using probes flagged as "IsWellAboveBG." With the use of TargetScan 6.2 algorithms, the miRNA target sites were predicted in those mRNAs that were upregulated (cutoff, 2-fold) but less enriched at least by 50% in AGO2 complexes of Dicer −/− BMDMs compared with Dicer +/+ BMDMs. 
RNA-Sequencing
Quantitative Real-Time Polymerase Chain Reaction
Total RNA was reverse-transcribed with a high-capacity cDNA reverse transcription kit or TaqMan MicroRNA Reverse Transcription Kit (Thermo Fisher Scientific). The mRNA quantitative real-time polymerase chain reaction (PCR) assay was performed with gene-specific primers (Table II in 
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reference genes (b2m, Gapdh, and Tbp for mRNA; U6 and sno135 for miRNA), scaled to the sample with the lowest expression (qbase software, Biogazelle), and logarithmically transformed (log10).
Human Carotid Lesion Samples
Human atherosclerotic lesion specimens were obtained from 23 patients (mean age, 75±8 years; 55% were symptomatic; 35% female and 65% male) during endarterectomy. One half of each sample was immediately stored in RNAlater for RNA isolation, and the other half was fixed in paraformaldehyde followed by paraffin embedding and sectioning. The sections were stained with Movat pentachrome staining, and the necrotic core areas were quantified with ImageJ. The Ethics Committee of the Medical Faculty at RWTH Aachen University approved the study protocol for the collection of human atherosclerotic plaque samples, and written informed consent was obtained from all participating subjects.
In Vivo TSB Treatment
After 8 weeks of HFD feeding, male Apoe −/− mice (6-8 weeks old) were randomized to the different experimental groups and injected once weekly via the tail vein with miR10a/Lcor or control TSBs (20 mg/kg, Exiqon) for 4 weeks. During the injection period, mice were fed a HFD. The tissues were harvested 1 week after the last injection.
Statistical Analysis
Two groups were compared by the unpaired Student t test, and >2 groups were compared by 1-way or 2-way ANOVA, depending on the number of grouping variables (Prism, GraphPad Software). For post hoc multiple comparisons after ANOVA, the Tukey-Kramer test was used to compare every mean with every other mean, and unprotected Fisher least significant difference test was performed for planned comparisons without correction. Data from the human plaque samples were analyzed with Pearson correlation coefficient. Values of P<0.05 were considered statistically significant.
Data Availability
The RNA sequencing, AGO2-RIP-chip, and miRNA quantitative PCR array data have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) and are accessible with Gene Expression Omnibus series accession number GSE87721 (AGO2-RIP-chip and miRNA quantitative PCR array) and GSE106854 (RNA sequencing).
RESULTS
Dicer Deletion in Macrophages Leads to Enhanced Atherosclerosis in Apoe −/− Mice
To investigate the role of macrophage Dicer in atherosclerosis, we generated Apoe-deficient mice with a myeloid cell-specific knockout of Dicer (LysM Figure 1E ). However, circulating cholesterol levels and leukocyte counts in Apoe −/− mice were not changed by Dicer ablation in macrophages (Table III in the onlineonly Data Supplement). Taken together, our data indicate that macrophage Dicer prevents atherosclerosis by decreasing inflammation, lipid accumulation, and apoptosis of lesional macrophages.
Dicer Promotes Alternative Macrophage Activation Through Metabolic Reprogramming
Next, we studied the effect of Dicer on macrophage polarization. In resting, IL-4-, and lipopolysaccharide/ interferon-γ (IFN-γ)-stimulated BMDMs, Dicer deficiency increased Il1b and Ccl2 expression levels and downregulated the AAM marker Mrc1 (Figure 2A) . However, opposite to the effect in lipopolysaccharide/ IFN-γ-treated macrophages, Dicer knockout upregulated Nos2 and Tnf expression and downregulated the expression of the AAM markers Fizz1 and Ym1, in resting and IL-4-treated BMDMs (Figure 2A (Figure 2C) . However, Dicer knockout did not alter the OCR in lipopolysaccharide/IFN-γ-treated BMDMs (Figure 2C ). In addition, deletion of Dicer did not affect the extracellular acidification rate in resting, IL-4-, or 
Dicer-Induced Oxidative Metabolism Limits Foam Cell Formation
AAMs are characterized by less lipid droplet formation and increased lipolysis of LDL-derived triglycerides com- ORIGINAL RESEARCH ARTICLE pared with inflammatory macrophages. 22 Hence, we aimed to study the effect of Dicer on foam cell formation. Treatment with oxidized LDL (oxLDL) for 72 hours, which results in foam cell formation, increased basal respiration and the maximal respiratory capacity in BMDMs compared with native LDL and vehicle treatment ( Figure 3A) . In contrast, oxLDL treatment for 24 or 48 hours did not affect the OCR ( Figure III (Figure 3B and 3C) .
Dicer knockout limited oxLDL-induced mitochondrial respiration ( Figure 3D ) and upregulation of Sirt1, Ppargc1b, Acox3, Hadhb, and Uqcrq expression (Figure 3E ) but increased lipid accumulation ( Figure 3F ) in BMDM-derived foam cells. Fizz1 expression was reduced in Dicer −/− BMDMs compared with the wild-type control after oxLDL treatment ( Figure 3C ). Moreover, blocking the transport of fatty acyl chains into mitochondria with etomoxir decreased the OCR ( Figure 3G ) and enhanced the lipid accumulation in oxLDL-treated BMDMs ( Figure 3F ). The effect of etomoxir on foam cell formation was absent in Dicer −/− BMDMs ( Figure 3F ). These findings indicate that excessive lipid accumulation in macrophages is balanced by Dicer-induced oxidative metabolism of fatty acids.
Dicer Drives Macrophage Metabolic Reprogramming by Suppressing Lcor and Nuclear Receptor Corepressor 2
To determine miRNA targets regulated by Dicer knockout, we performed miRNA quantitative PCR array and AGO2-RIP-chip analysis in Dicer −/− BMDMs and Dicer
BMDMs. Dicer deletion resulted in downregulation of 137 miRNAs, including miRNAs highly expressed in macrophages such as miR-146a, miR-223, let-7 miRNA family members, and miR-142-3p 28 ( Figure 4A and Table V D, E, and G) , 1-way ANOVA followed by the Fisher least significant difference (A and B) , or Tukey-Kramer (C) test and 2-way ANOVA followed by Tukey-Kramer test (F). ETC indicates electron transport chain; FAO, fatty acid oxidation; TCA, tricarboxylic acid cycle.
sites for the miRNAs downregulated in Dicer −/− BMDMs as predicted by the TargetScan algorithm ( Figure 4B ). The highest number of conserved miRNA binding sites (eg, for miR-10a/b, let-7, miR-30, and miR-195) was predicted in the 3′ untranslated region (UTR) of Lcor mRNA ( Figure 4B ), which encodes for a protein that interacts with RXRα. 39 Binding sites for miR-10 and miR-30 family members were also predicted in the nuclear receptor corepressor 2 (Ncor2) mRNA ( Figure 4B ), which translates into a protein that inhibits PPARα activation and mitochondrial oxidative metabolism. 40 Figure 4H ) but reduced the number of nonrespiring mitochondria ( Figure 4I ). Next we studied the effect of LCoR on the transcriptional activity of RXRα. We transfected HEK293T cells with a vector containing the luciferase gene controlled by RXR transcriptional response elements and a vector expressing RXRα. Overexpression of Lcor inhibited luciferase activity in 9-cis-retinoic acidtreated cells, indicating that LCoR inhibits RXRα activity ( Figure 4J ). Treatment of IL-4-treated Dicer −/− BMDMs with the RXRα agonist CD3254 increased Fizz1 and Ym1 expression ( Figure 4K ). These data indicate that Dicer promotes mitochondrial oxidative metabolism in macrophages by suppressing Lcor and Ncor2.
miR-10a and let-7b Mediate the Effect of Dicer on Macrophage Oxidative Metabolism
To determine the miRNAs that are responsible for the phenotype of Dicer −/− macrophages, we studied the role of 13 miRNAs downregulated in Dicer −/− macrophages and predicted to target Lcor in the cellular oxygen consumption of AAMs. Transfection of miR-10a, let-7b, or miR-195a mimics increased mitochondrial respiration in IL-4-treated Dicer −/− BMDMs ( Figure 5A ). In contrast, miR-103, let-7a/i, miR-98, or miR-200b mimic treatment did not affect and miR-30a, miR-106b, miR-142, We then studied the role of Dicer in the regulation of miR-10a and let-7b expression levels in lesional macrophages. In contrast to M-Dicer +/+ mice, miR-10a and let-7b expression was reduced in lesional macrophages, as determined by combined in situ PCR and MAC2 immunostaining ( Figure 5F ) and in atherosclerotic aortas ( Figure 5G ) from M-Dicer −/− mice. In humans, miR10a and let-7b expression levels were lower in carotid plaques than in the vessel wall ( Figure 5H ) and negatively correlated with the necrotic core area in carotid le- Figure 5I ). These data suggest an atheroprotective role of miR-10a and let-7b expression in macrophages.
miR-10a Promotes Oxidative Metabolism by Targeting Lcor and Ncor2
Next, we studied the mechanisms by which miR-10a and let-7b affect metabolism during macrophage polarization. IL-4 and lipopolysaccharide/IFN-γ treatment upregulated and downregulated let-7b expression in BMDMs, respectively, but did not change miR-10a expression ( Figure VIIC in the online-only Data Supplement). miR-10a inhibition reduced Ppargc1b, Fizz1, and Ym1 expression ( Figure 6A ) and inhibition of let7b downregulated Sirt1, Ppargc1b, Mrc1, and Ym1 expression ( Figure 6B ) in IL-4-treated Dicer +/+ BMDMs. Locked nucleic acid-modified oligonucleotides and target site blockers (TSBs) were designed to block the interaction between miR-10a and Lcor (miR10a/Lcor TSBs) or Ncor2 (miR10a/Ncor2 TSBs) and between let-7b and Lcor (let7b/Lcor TSBs). We found that the TSBs specifically upregulated the expression of either Lcor or Ncor2 in BMDMs ( Figure (Figure 6F) .
In addition, transfection with miR10a/Lcor TSBs and, to a lesser extent, with miR10a/Ncor2 TSBs, but not with let7b/Lcor TSBs, reduced the basal OCR (Figure 6G ) and cell survival ( Figure 6H ) of IL-4-treated BMDMs. In oxLDL-treated BMDMs, transfection with miR10a/Lcor TSBs or miR10a/Ncor2 TSBs decreased the basal OCR ( Figure 6I ), reduced Sirt1 and Ppargc1b expression ( Figure 6J ), and enhanced lipid accumulation ( Figure 6K ). Taken together, these results suggest that miR-10a contributes to the effect of Dicer on mitochondrial respiration in AAMs and foam cells by targeting Lcor and Ncor2.
Therefore, we investigated the role of miR-10a-mediated suppression of Lcor in atherosclerosis. Treatment of Apoe −/− mice with miR10a/Lcor TSBs during the last 4 weeks of a 12-week HFD feeding program increased atherosclerotic lesion formation in the aortic arch compared with control TSBs (Figure 6L ). Moreover, miR10a/Lcor TSB treatment reduced Sirt1, Ppargc1b, Mrc1, and Ym1 expression and increased Lcor, Nos2, Tnf, and Ccl2 expression in the aorta ( Figure 6M ). Injection of miR10a/Lcor TSBs increased the nuclear accumulation of LCoR in lesional macrophages ( Figure VIIE in the online-only Data Supplement). The body weights, circulating leukocyte counts, and blood cholesterol levels did not differ between the groups (Table VII in the online-only Data Supplement). Hence, miR-10a may limit atherosclerotic lesion formation by suppressing Lcor in macrophages.
DISCUSSION
Our results show that miRNA biogenesis by Dicer plays a key role in the metabolic adaptation of macrophages to excessive fatty acid availability. Dicer increased mitochondrial FAO capacity in AAMs and foam cells by generating miRNAs such as miR-10a that promoted the expression of genes involved in mitochondrial oxidative metabolism by targeting Lcor. Dicer-mediated fatty acid degradation in macrophages reduced foam cell formation and lipotoxic stress and limited the progression of atherosclerosis to vulnerable lesions ( Figure VIII in the online-only Data Supplement).
In contrast to storing fatty acids as triglycerides in lipid droplets in inflammatory macrophages, increased fatty acid availability through lysosomal lipolysis in AAMs results in enhanced OXPHOS and FAO, 22 which increases ATP production and enhances cell survival and phagocytosis. 22, 27 Moreover, mitochondrial ATP production in AAMs is associated with decreased mitochondrial reactive oxygen species production and thus promotes an anti-inflammatory state. 18, 41 We found that Dicer plays an essential role in the metabolic programming of IL-4-induced AAM polarization by enhancing mitochondrial biogenesis, OXPHOS, and ATP production. As a result, Dicer reduced inflammatory signaling and cytokine production in AAMs, similar to tumor-associated macrophages. 34 In vivo, myeloid cell-specific Dicer knockout induced a phenotypic shift of lesional macrophages toward a proinflammatory state, indicating that Dicer-mediated metabolic programming of AAMs limits the progression of atherosclerosis. Notably, increased oxygen consumption of macrophage-derived foam cells in early lesions ceases in advanced atherosclerosis. 5 Our findings reveal that excess lipid storage in foam cells triggers Dicer-mediated fatty acid degradation by mitochondrial respiration to reduce the triglyceride content in lipid droplets. 4 Thus, FAO and OXPHOS may protect lesional foam cells during early atherosclerosis from lipotoxicity as a result of the accumulation of triglycerides, 7 whereas the shutdown of mitochondrial respiration in lesional macrophages during inflammatory polarization may result in foam cell death and necrotic core October 30, 2018 Circulation. 42 Taken together, our findings indicate that Dicer expression in macrophages limits advanced atherosclerosis by increasing mitochondrial fatty acid degradation in foam cells. In contrast to its role in macrophages, endothelial Dicer promotes atherosclerosis by enhancing early monocyte recruitment. 43 Thus, the net effect of Dicer in the different cell types may depend heavily on the stage of atherosclerosis.
To investigate the mechanism by which Dicer promotes oxidative metabolism, we analyzed the miRNA targets in macrophages. We found that 2 nuclear receptor corepressors, Lcor and Ncor2, mediate the effect of Dicer knockout on mitochondrial respiration in AAMs. Notably, interaction with Ncor2 inhibits the activity of PPARs such as PPARα, which positively regulates the expression of Ppargc1b, Sirt1, and genes involved in FAO and OXPHOS, [44] [45] [46] and thereby reduces mitochondrial oxidative metabolism and increases the triglyceride content in adipocytes. 40 Hence, our results indicate a similar role of Ncor2 in mitochondrial function in AAMs. Moreover, Lcor attenuates agonistactivated nuclear receptor signaling, for example, the estrogen receptor-α and vitamin D receptor, by histone deacetylase-dependent and -independent mechanisms. 39 In addition, Lcor promotes Kruppel-like factor 6-mediated transcriptional repression of target genes. 47 We found that Lcor interacts with RXRα and inhibits RXR activity. RXRα acts as a sensor for mitochondrial function and upregulates mitochondrial genes by interacting with PGC-1. 48 Among the miRNAs downregulated by Dicer knockout, miR-10a, let-7b, and miR-195a enhanced cellular oxygen consumption and suppressed Lcor expression, indicating that these 3 miRNAs contribute to the effect of Dicer in macrophages. In addition to target Ncor2, which is in line with previous reports, 49 miR-10a directly targets Lcor and thereby promotes mitochondrial function and an anti-inflammatory macrophage phenotype. Inhibition of this mechanism may play a key role in the proatherogenic and proinflammatory effect of TSBs that block the interaction between miR10a and Lcor. Accordingly, miR-10a inhibits inflammatory monocyte activation by downregulating several components of the nuclear factor-κB pathway. 50 In contrast to miR-10a, the effect of let-7b on oxidative metabolism in macrophages was not meditated through targeting Lcor, indicating that other let-7b targets are involved in the regulation of macrophage metabolic reprogramming. Other let-7 family members such as let-7a, let-7i, and miR-98 did not affect metabolic reprogramming in AAMs, suggesting that the seed sequence is not essential for the let-7 effect in macrophages. Accordingly, the finding that let-7d partially mediates the effect of Dicer on polarization of tumor-associated macrophages may be the result of a different mechanism. 34 miR-195, the third miRNA that mediated the effect of Dicer on macrophage metabolism, suppressed Lcor not through direct targeting of its 3′-UTR. Hence, as-yet unknown miR-195 targets may promote Lcor expression and inhibit mitochondrial function.
CONCLUSIONS
Our findings demonstrate a critical role of Dicer in enhancing mitochondrial oxidative metabolism during alternative macrophage activation and foam cell formation by suppressing nuclear receptor corepressor Lcor through miR-10a, indicating that miRNAs coordinate the inflammatory response and lipid metabolism in macrophages by regulating mitochondrial function.
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